Print Page  Close Window

SEC Filings

OREXIGEN THERAPEUTICS, INC. filed this Form 8-A12B on 04/18/2007
Entire Document

     Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.
Dated: April 18, 2007  OREXIGEN THERAPEUTICS, INC.
  By:   /s/ Gary D. Tollefson    
  Name:   Gary D. Tollefson, M.D., Ph.D.   
  Title:   President and Chief Executive Officer